Salbutamol dry-powder inhalation - Chiesi

Drug Profile

Salbutamol dry-powder inhalation - Chiesi

Alternative Names: Albuterol dry-powder inhalation - Chiesi; Albuterol Pulvinal - Chiesi; Bumol; Butovent; Butovent Pulvinal; Easivent Sal; Normobron; Normobron Pulvinal; Pulvinal Salbutamol; Salbutamol Pulvinal - Chiesi

Latest Information Update: 01 Apr 2015

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Chiesi
  • Developer Chiesi; Trinity-Chiesi Pharmaceuticals
  • Class Antiasthmatics; Antibronchitics; Bronchodilators; Ethanolamines; Phenethylamines; Small molecules; Tocolytics
  • Mechanism of Action Beta 2 adrenergic receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Marketed Asthma

Most Recent Events

  • 18 Sep 2001 First global launch of Pulvinal® Salbutamol in the UK
  • 18 Sep 2001 Launched for Asthma in United Kingdom (Inhalation)
  • 09 Jul 2001 Registered for Asthma in Denmark (Inhalation)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top